Our results also highlight the importance of the Wnt/β-catenin and their transcriptional targets (including c-myc, survivin, cyclin D1, CDK4, and MMPs), which may serve as future targets for the development of therapeutic strategies against human melanoma. The gene discussed is BIRC5; the disease is melanoma.